Relationship among cholesterol, superoxide anion and endothelium-dependent relaxation in diabetic rats

European Journal of Pharmacology

Volumn 367, Issue 2-3, 1999, Pages 213-222

  Kobayashi, Tsuneo ^a   Kamata, Katsuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Diabetes; LDL (low density lipoprotein); LDL receptor; Lipid peroxidation; Plasma glucose; Relaxation; Superoxide anion; Superoxide dismutase

Indexed keywords

ACETYLCHOLINE; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; AORTA STRIP; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; CHOLESTEROL, LDL; DIABETES MELLITUS, EXPERIMENTAL; ISOMETRIC CONTRACTION; LIPID PEROXIDATION; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; OLIGONUCLEOTIDES; RATS; RATS, WISTAR; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE; VASODILATOR AGENTS;

EID: 0032971418     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00971-6     Document Type: Article

References (55)

1. Abe K., Kogure K., Itoyama Y. Rapid and semiquantitative analysis of HSP 72 and HSC 73 heat shock mRNA by mimic RT-PCR. Brain Res. 683:1995;251-253.
2. Beckman J.S., Beckman T., Chen J., Marahall P.A., Freeman B. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
3. 14C ]sucrose-labeled low-density lipoprotein in rats J. Biol. Chem. 257:1982;8001-8008.
4. Chait A., Bierman E., Albers J. Low-density lipoprotein receptor activity in cultured human skin fibroblasts: mechanism of insulin induced stimulation. J. Clin. Invest. 64:1979;1309-1319.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Ciaraldi T.P., Gilmore A., Olefsky J.M., Goldberg M., Heidenreich K.A. In vitro studies on the action of CS-045: a new antidiabetic agent. Metabolism. 39:1990;1056-1062.
7. Dubowski K.M. An toluidine method for body-fluid glucose determination. Clin. Chem. 8:1962;215-235.
8. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
9. Fujiwara T., Yoshioka S., Yoshioka T., Ushiama I., Horikoshi H. Characterization of a new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes. 37:1988;1549-1558.
10. Gryglewski R.J., Palmer R.M.J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
11. Hattori Y., Kawasaki H., Abe K., Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261:1991;H1086-H1094.
12. Heinecke J.W., Baker L., Rosen H., Chait A. Superoxide-mediated modification of low-density lipoprotein by arterial smooth muscle cells. J. Clin. Invest. 77:1986;757-761.
13. Heinecke J.W., Kawamura M., Suzuki I., Chait A. Oxidation of low-density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. J. Lipid Res. 34:1993;2051-2061.
14. Kamata K., Kobayashi T. Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br. J. Pharmacol. 119:1996;583-589.
15. Kamata K., Miyata N., Kasuya Y. Mechanisms of increased responses of the aorta to adrenoceptor agonists in streptozotocin N induced diabetic rats. J. Pharmacobiol.-Dyn. 11:1988;707-713.
16. Kamata K., Miyata N., Kasuya Y. Impairment of endothelium dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 97:1989;614-618.
17. Kamata K., Sugiura M., Kojima S., Kasuya Y. Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine. Br. J. Pharmacol. 118:1996;385-391.
18. Kawamura M., Heinecke J.W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low-density lipoprotein by a superoxide-dependent pathway. J. Clin. Invest. 94:1994;771-778.
19. Keaney J.F. Jr., Xu A., Cunningham D., Jackson T., Frei B., Vita J.A. Dietary probucol preserves endothelial function in cholesterol fed rabbits by limiting vascular oxidative stress and superoxide generation. J. Clin. Invest. 95:1995;2520-2529.
20. Keegan A., Walbank H., Cotter M.A., Cameron N.E. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia. 38:1995;1475-1478.
21. Koelz H.R., Sherril B.C., Dietschy J.M. Correlation of low and high density lipoprotein binding in vivo with rates of lipoprotein degradation in the rat. J. Biol. Chem. 257:1982;8061-8072.
22. Kovanen P.T., Bilheimer D.W., Goldstein J.L., Jaramillo J.L., Brown M.S. Regulatory role for hepatic low-density lipoprotein receptors in the dog. Proc. Natl. Acad. Sci. USA. 78:1981;1194-1198.
23. Krone W., Naegele H., Behnke B., Greten H. Opposite effects of insulin and catecholamines on LDL-receptor activity in human mononuclear leukocytes. Diabetes. 37:1988;1386-1391.
24. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolethicin in modified low-density lipoprotein. Nature. 344:1990;160-162.
25. Langenstroer P., Pieper G.M. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am. J. Physiol. 263:1992;H257-H265.
26. Loven D.P., Schedl H.P., Oberley L.W., Wilson H.D., Bruch L. Superoxide dismutase activity in the intestinal mucosa of the streptozotocin-diabetic rat. Endocrinology. 111:1982;737-742.
27. Mantha S.V., Prasad M., Kalra J., Prasad K. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. Atherosclerosis. 101:1993;135-144.
28. Mazzone T., Foster D., Chait A. In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes. 33:1984;333-338.
29. Marian K.B., Martip W. Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by superoxide anion in rat aorta. Br. J. Pharmacol. 115:1995;993-1000.
30. Mugge A., Elwell J.H., Peterson T.E., Hofmeyer T.G., Heistad D.D., Hrrison D.G. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res. 69:1991;1293.
31. Nakai T., Oida K., Tamai T., Kutsumi Y., Miyabo S., Takeda R. Characteristics of lipoprotein receptors of the isolated liver parenchymal cells prepared from the streptozotocin-induced diabetic rats. Life Sci. 38:1985;653-662.
32. Omar H.A., Cherry P.D., Mortelliti M.P., Burke-Wolin T., Wolin M.S. Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation. Circ. Res. 69:1991;601-608.
33. Oyama Y., Kawasaki H., Hattori Y., Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol. 132:1986;75-78.
34. Pagano P.J., Tornhein K., Cohen R.A. Superoxide anion production by rabbit thoracic aorta: effect of endothelium-derived nitric oxide. Am. J. Physiol. 265:1993;H707-H712.
35. Pieper G.M., Gross G.J. Oxygen free radical abolish endothelium dependent relaxation in diabetic rat aorta. Am. J. Physiol. 255:1988;H825.
36. Pieper G.M., Mei D.A., Langenstroer P., O'Rourke S.T. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am. J. Physiol. 263:1992;H676-H680.
37. Poston L., Taylor P.D. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sci. 88:1995;245-255.
38. Rajavashisth T.B., Andalibi A., Territo M.C., Berliner J.A., Navab M., Fogelman A.M., Lusis A.J. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoprotein. Nature. 344:1990;254-257.
39. Rayyes O.A., Florn C.-H. Troglitazone upregulates LDL receptor activity in HepG2 cells. Diabetes. 47:1998;1193-1198.
40. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 250:1986;H822-H827.
41. Rudling M., Angelin B. Stimulation of rat hepatic low-density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo. J. Clin. Invest. 91:1993;2796-2805.
42. Rudling M., Angelin B. Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low-density lipoprotein-receptor expression. Proc. Natl. Acad. Sci. USA. 90:1993;8851-8855.
43. Simon B.C., Cunningham L.D., Cohen R.A. Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J. Clin. Invest. 86:1990;75-79.
44. Simon B.C., Haudenschild C.C., Cohen R.A. Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J. Cardiovasc. Pharmacol. 21:1993;893-901.
45. Steinberg U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg G.D. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
46. Steinbrecher U.P. Role of superoxide in endothelial-cell modification of low-density lipoproteins. Biochim. Biophys. Acta. 959:1988;20-30.
47. Swami S., Sztalryd C., Kraemer F.B. Effects of streptozotocin induced diabetes on low-density lipoprotein receptor expression in rats adipose tissue. J. Lipid Res. 37:1996;229-236.
48. Takahashi S., Kawarabayashi Y., Nakai T., Sakai J., Yamamoto T. Rabbit very low-density lipoprotein receptor: a low-density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89:1992;9252-9256.
49. Takahashi S., Suzuki J., Kohno M., Oida K., Tamai T., Miyabe S., Yamamoto T., Nakai T. Enhancement of the binding of triglyceride-rich lipoproteins to the very low-density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 270:1995;15747-15754.
50. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries. Role of Scavenger receptor and endothelium-derived nitric oxide. Circulation. 83:1991;2012-2020.
51. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 263:1992;H321.
52. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., Mark A.C. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 97:1996;2228.
53. Wade D.P., Knight B.L., Soutar A.K. Hormonal regulation of low-density lipoprotein (LDL) receptor activity in human hepatoma HepG2 cells. Insulin increases LDL receptor activity and diminishes its suppression by exogenous LDL. Eur. J. Biochem. 174:1988;213-218.
54. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A., Tarpey M.M. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA. 91:1994;1044-1048.
55. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:1976;212-216.